Severe polyneuropathy after using nitrous oxide as an anaesthetic. Is this pathology preventable?;Polineuropatia grave tras utilizacion de oxido nitroso como anestesico. Una patologia prevenible?

Revista de Neurologia

Volumn 29, Issue 1, 1999, Pages 36-38

  Alarcia, R ^a,b   Ara, J R ^a   Serrano, M ^a   Garcia M ^a   Latorre, A Ma ^a   Capablo, J L ^a  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b NONE   (Spain)

Author keywords

Anaesthesia; H mocystein; Methylmalonic acid; Nitrous oxide; Polyneuropathy; Vitamin B12

Indexed keywords

COBALAMIN; CYANOCOBALAMIN; HOMOCYSTEINE; HYDROXOCOBALAMIN; INTRINSIC FACTOR; METHYLMALONIC ACID; NITROUS OXIDE; INHALATION ANESTHETIC AGENT;

AGED; ANESTHESIA; ARTICLE; CASE REPORT; CYANOCOBALAMIN DEFICIENCY; DISEASE SEVERITY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MOTOR NERVE CONDUCTION; POLYNEUROPATHY; SCHILLING TEST; SENSORY NEUROPATHY; WALKING; BLOOD VESSEL TRANSPLANTATION; CHEMICALLY INDUCED DISORDER; DEMYELINATING DISEASE; DRUG ANTAGONISM; NERVE FIBER; PARAPLEGIA; PATHOLOGY; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; SENSORY DYSFUNCTION;

AGED; ANESTHETICS, INHALATION; AXONS; BLOOD VESSEL PROSTHESIS IMPLANTATION; DEMYELINATING DISEASES; HUMANS; INTRINSIC FACTOR; MALE; NITROUS OXIDE; PARAPLEGIA; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; SENSATION DISORDERS; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 0033161784     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.2901.99093     Document Type: Article

References (13)

1. Kinsella LJ, Green R. Anesthesia paresthetic: nitrous oxide-induced cobalamin deficiency. Neurology 1995; 45: 1608-10.
2. Maso E, Roquer J. Degeneración combinada subaguda de la médula. En Codina Puiggrós A, ed. Tratado de neurología. Madrid: ELA; 1994. p. 514-5.
3. Lassen HCA, Henriksen E, Neukirch F, Kristensen HS. Treatment of tetanus: severe bone-marrow depression after prolonged nitrous oxide anesthesia. Lancet 1956; 1: 527-30.
4. Chanarin I, Deacon R, Lumb M, Muir M, Perry J. Cobalamin-folate interrelations: a critical review. Blood 1985; 66: 479-89.
5. Hadzic A, Glab K, Sanborn KV, Thys DM. Severe neurologic deficit after nitrous oxide anesthesia. Anesthesiology 1995; 83: 863-6.
6. 12. En Adams RD, Victor M, Ropper AH, eds. Principios de neurología. 6 ed. México: McGraw-Hill; 1997. p. 997-9.
7. 12 deficiency. J Neurosurg 1990; 72: 732-6.
8. Babior BM, Bunn HF. Megaloblastic anemias. In Braunwald E, Isselbacherk KJ, Petersdorf RG, Wilson JD, Martin JB, Fauci AS, eds. Harrison's principles of internal medicine. 11 ed. New York: McGraw-Hill; 1987. p. 1498-504.
9. O'Sullivan H, Jennings F, Ward K, McCann S, Scott JM, Weir DG. Human bone marrow biochemical function and megaloblastic hematopoiesis after nitrous oxide anesthesia. Anesthesiology 1981; 55: 645-9.
10. Girón JM, Muñoz A, Caro P, Rodríguez F, Vila MJ. Anestesia parestésica: aportación de un nuevo caso y estudio evolutivo por resonancia magnética. Neurología 1998; 13: 307-10.
11. Green R, Kinsella LJ. Current concepts in the diagnosis of cobalamin deficiency. Neurology 1995; 45: 1435-40.
12. 12 deficiency among geriatric out patients. J Fam Pract 1992; 35: 524-8.
13. Lindenbaum J, Healton EB, Savage DG, Brust JCM, Garrett TJ, Podell ER, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia of macrocytosis. N Engl J Med 1998; 318: 1720-7.